Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PROTECT: Certican vs CNI in Liver Transplant
NCT00378014Phase 3Completed
- Sponsor
- Novartis
- Start
- Aug 2006
- Primary completion
- Jan 2013
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 3 trial of everolimus in Liver transplant rejection, sponsored by Novartis. Started Aug 2006; status: completed.
02
Drugs
everolimus
03
Conditions
Liver transplant rejection
Beyond the preview
Go deeper on NCT00378014.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00378014.